GSK's major growth drivers, Shingrix and Arexvy, along with recent legal progress, make its current undervaluation ...

There was a slightly worse-than-expected performance for respiratory syncytial virus (RSV) vaccine Arexvy and a decline in sales for GSK's important vaccines business. While outside the usual RSV ...

Recent findings from a multi-state study reveal that the RSV vaccine is approximately 80% effective in preventing severe ...

Neomycin is an antibiotic that interferes with bacterial protein synthesis by binding primarily to the 30S subunit of bacterial ribosomes. Many vaccines contain trace amounts of neomycin to ...

We’ve taken a look at what a vaccine actually is and how long it might take until we get one, and news outlets have been reporting on the progress research teams around the world are making.

Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., October 23, 2024. REUTERS/Brendan McDermid/File Photo The Nasdaq ended higher on Friday, driven by megacap ...